Anna Maria Scattolin

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Renato Bassan, Orietta Spinelli, Elena Oldani et al. · Blood · 2009 · 430 citations · Full text

Medicine, Oncology, Chemotherapy +13

Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Corrado Girmenia, Gian María Rossolini, Alfonso Piciocchi et al. · Bone Marrow Transplantation · 2014 · 188 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome

Federico Lussana, Tamara Intermesoli, Francesca Gianni et al. · Biology of Blood and Marrow Transplantation · 2016 · 87 citations · Full text

Medicine, Hematology, Oncology +15

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Fabio Guolo, Luana Fianchi, Paola Minetto et al. · Blood Cancer Journal · 2020 · 57 citations · Full text

Medicine, Hematology, Oncology +13